David Bates, M.D., M.Sc.; John Murphy, Pharm.D., FCCP; John Rotschafer, Pharm.D., FCCP; and Ann Wittkowsky, Pharm.D., FCCP, CACP, have been selected by the College’s Awards Committee to receive the association’s prestigious 2012 Therapeutic Frontiers Lecture, Education, Russell R. Miller, and Clinical Practice Awards, respectively. The awards will be presented in Hollywood, Florida, on Sunday morning, October 21, during the Opening General Session of the College’s 2012 Annual Meeting.
David Bates, M.D., M.Sc.
The ACCP Therapeutic Frontiers Lecture Award recognizes an individual, including ACCP member and nonmember nominees, who has made outstanding contributions to pharmacotherapeutics in his or her field. Among the criteria for this award is the broad acknowledgment that the recipient is currently considered at the leading edge of research in the field. David W. Bates is chief quality officer and senior vice president, Brigham and Women’s Hospital; chief, Division of General Internal Medicine, Brigham and Women’s Hospital; and medical director of Clinical and Quality Analysis, Partners Healthcare, Boston, Massachusetts. He is well known internationally for his work in medication error prevention and patient safety. One of Dr. Bates’ nominators captured very well the reasons he was selected for this award,
It is literally impossible to search for contemporary biomedical literature related to clinical decision support (CDS), computerized provider order entry (CPOE), or electronic health records (EHR) without identifying myriad seminal publications authored by Dr. Bates and his collaborators. Indeed, he and his research group are responsible for more than 300 peer-reviewed publications. In the mid-1990s, Dr. Bates was one of the first investigators in the world to report critical evaluations of CPOE. Many of his papers document the ability to use technology to prevent medication errors and their related adverse effects. David has routinely used pharmacists as key members of the health care team to implement clinical programs and conduct clinical research.
Dr. Sheryl Herner, chair of the 2011 Organizational Affairs Committee, which nominated Dr. Bates for this award, wrote in her nomination letter,
Dr. Bates is perhaps the single best-recognized researcher in the field of CDS. For more than two decades, he has been involved in key research aimed at improving the clinical use of drugs, both in the acute care and ambulatory care settings. Moreover, Dr. Bates has extensively and consistently collaborated with clinical pharmacists to collect, analyze, and disseminate important data related to the prevention of adverse drug events.
Dr. Bates is currently the external program lead for research in the World Health Organization’s Global Alliance for Patient Safety. He is also president-elect of the International Society for Quality in Healthcare (ISQua) and serves as an associate editor of the Journal of Patient Safety. He has been elected to the Institute of Medicine, the American Society for Clinical Investigation, the Association of American Physicians, and the American College of Medical Informatics, and he was chairman of the Board of the American Medical Informatics Association. He is credited with more than 600 peer-reviewed publications. Dr. Bates’ lecture, titled “The Effects of the Electronic Revolution on Therapeutics,” will be delivered at 7:45 a.m. at the beginning of Sunday’s Opening General Session.
John Murphy, Pharm.D., FCCP
The Education Award recognizes an ACCP member who has made substantial and outstanding contributions to clinical pharmacy education at either the undergraduate or the postgraduate level. John E. Murphy, Pharm.D., is professor of pharmacy practice and science and associate dean for Academic and Professional Affairs at the College of Pharmacy, as well as professor of Clinical, Family and Community Medicine at the College of Medicine at the University of Arizona in Tucson. He is also an honorary professor at the University of Otago School of Pharmacy in Dunedin, New Zealand. Letters written by colleagues in support of Dr. Murphy’s nomination speak to his dedication to pharmacy education. Dr. Lyle Bootman, dean and professor at the University of Arizona College of Pharmacy, wrote in his letter of support,
[Dr. Murphy] is one of the few faculty members who volunteers at all levels of the college and university to enhance our educational programs…, I have been most impressed with his efforts to understand the potential for teaching Pharm.D. students about the research process. This has also been an important part of his career over many years. His longitudinal work documenting research training in US Colleges and Schools of Pharmacy has been valuable in promoting these activities…. As all ACCP members should know, Dr. Murphy has been a key player on important committees that created ACCP statements on the role of residencies in the development of clinical pharmacists and the advancement of specialty recognition as a core demonstration of quality and knowledge. He has promoted the necessity of attaining a residency prior to entering clinical practice in a wide variety of venues and helps keep this message at the front of profession.
Dr. Brian Erstad, in his letter of nomination, commented on Dr. Murphy’s commitment to interprofessional education, a subject that has emerged as one of the awardee’s major interest areas,
Dr. Murphy has served since 2003 as a core member and the College of Pharmacy’s representative on the University of Arizona Health Sciences Center Interprofessional Working Group. This team, consisting of representatives from medicine, public health and nursing, develops major interprofessional events through the year that bring together hundreds of students from the above colleges as well as law and social work. The events are designed to improve teamwork in the care of patients. A number of these activities have resulted in publications and national presentations at scientific and professional meetings.
Dr. Murphy is a member of the American Society of Health-System Pharmacists (ASHP) Commission on Credentialing (COC)—the body that sets the standards for and accredits the pharmacy residency and technician training programs in the United States. He is also a past president of ACCP, having served on the ACCP Board of Regents from 2007 until 2010. In addition, he served as president (1997–1998) and member of the Board of Directors (1994–1999) of the American Society of Health-System Pharmacists (ASHP) and as president of the Georgia Society of Hospital Pharmacists. He has been awarded fellow status in three organizations—ACCP, the American College of Clinical Pharmacology, and ASHP. Dr. Murphy has published more than 200 papers and four editions of the textbook titled Clinical Pharmacokinetics. He was codirector from 2000 to 2005 of the Arizona Clinical Research Training Program (AzCRTP), an NIH K30 Clinical Research Curriculum Award. His research interests include the prevention of drug-drug interactions, pharmacy education, and clinical pharmacokinetics.
John Rotschafer, Pharm.D., FCCP
Russell R. Miller was the founding editor of the College’s journal, Pharmacotherapy. The Russell R. Miller Award is presented in recognition of substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy. John C. Rotschafer, Pharm.D., FCCP, is professor (tenured) and former chair in the Department of Experimental and Clinical Pharmacology, where he directs the Antibiotic Pharmacodynamic Research Institute. Dr. Rotschafer has supervised the postdoctoral training of 22 fellows and been awarded fellowship grants in infectious diseases three times by the American College of Clinical Pharmacy and twice by the American Society of Hospital Pharmacists. He has been the author of more than 150 journal publications, has made more than 30 book contributions, and has more than 100 scientific abstracts. His primary professional interests are in the areas of antibiotic pharmacokinetics, pharmacodynamics, antibiotic resistance, and infectious diseases. In her letter of nomination, Dr. Elizabeth Hermsen focused on both the significance and sustained nature of Dr. Rotschafer’s contributions to the scientific literature,
His first publication occurred 1978, during his post-doctoral fellowship, and the most recent this year, clearly demonstrating a sustained record of excellence in the professional literature. Dr. Rotschafer has published in a number of highly-regarded journals…. Notably, Dr. Rotschafer’s research and publications shape much of what we know today about the pharmacokinetics, pharmacodynamics, and dosing of vancomycin, aminoglycosides, and fluoroquinolones. Moreover, John is one of few investigators to use an anaerobic chamber to conduct in vitro pharmacodynamic modeling, which has resulted in important information about differences in antibacterial pharmacodynamics in an anaerobic environment and against mixed infections.
Dr. Keith Rodvold from the University of Illinois College of Pharmacy also highlighted the sustained nature of Dr. Rotschafer’s scholarship in his letter of recommendation,
Early in his career, the majority of his publications focused on the clinical pharmacokinetics of aminoglycosides and vancomycin. Dr. Rotschafer’s pivotal and noteworthy manuscripts in major medical journals such as JAMA and Antimicrobial Agents and Chemotherapy established the importance of therapeutic drug monitoring, comparison in dosing methods, and differences in assay methodologies for these agents. His initial research in the 1980s and early 1990s has had a major impact on dosing strategies of vancomycin…. During the past 15 years, Dr. Rotschafer has established and maintained an anti-infective research laboratory to conduct translational research at the bench in an effort to answer clinical questions from the bedside. His in vitro model has allowed the evaluation of comparative pharmacokinetic-pharmacodynamic studies of anti-infective agents under aerobic and anaerobic conditions. In addition, Dr. Rotschafer has generously provided guidance and assistance to clinical pharmacists trying to establish similar in vitro models at their own research laboratories.
Finally, Professor Michael Rybak from Wayne State College of Pharmacy and Health Sciences commented on Dr. Rotschafer’s qualifications for this award,
Although John has many outstanding and well-cited publication sin the field of antimicrobial pharmacokinetics and pharmacodynamics, he is probably best known for his clinical and in vitro work on vancomycin and the fluoroquinolone antibiotics. In fact, it is John’s vast and extensive expertise on vancomycin that made him the perfect choice for committee membership and authorship on each of the newly revised vancomycin dosing and monitoring guidelines developed by ASHP, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. It is papers like these that have profound effect on clinical pharmacy practice and are highly impactful on the care of our patients.
Dr. Rotschafer has served on the editorial board for Antimicrobial Agents and Chemotherapy, Diagnostic Microbiology and Infectious Diseases, Journal of Infectious Disease Pharmacotherapy, Pharmacoeconomics: Infectious Diseases, Annals of Pharmacotherapy, and Pharmacotherapy (guest editor). He has also made more than 35 contributions to various textbooks related to infectious diseases, including Pharmacotherapy: A Pathophysiologic Approach. In 1989, he was recognized as a fellow in the American College of Clinical Pharmacy.
Ann Wittkowsky, Pharm.D., FCCP, CACP
The ACCP Clinical Practice Award is given to a College member who has made substantial and outstanding contributions to clinical pharmacy practice. The criteria considered in identifying potential candidates include exceptional leadership in developing innovative clinical pharmacy services and sustained excellence in providing them. Ann K. Wittkowsky, Pharm.D., FCCP, FASHP, CACP, is a clinical professor of pharmacy at the University of Washington School of Pharmacy and director of Anticoagulation Services at the University of Washington Medical Center. As a clinician and educator in the field of antithrombotic pharmacotherapy, she has contributed extensively to the care of patients and the education of health care providers regarding antithrombotic pharmacotherapy. She is the author of more than 100 scientific papers, book chapters, and abstracts and is coeditor of the textbook Managing Oral Anticoagulation Therapy: Clinical and Operational Guidelines. She has lectured widely throughout the United States and Canada, maintains an active clinical research program, and is board certified as an anticoagulation care provider. In recommending Dr. Wittkowsky for the Clinical Practice Award, Dr. Edith Nutescu wrote in her letter of nomination,
Dr. Wittkowsky has long established herself as a clinician leader in the field of anticoagulation and cardiovascular thrombosis. Her contributions to our profession and the management of patients with thrombotic disorders have been exemplary, impacting practice patterns and patient care not only in the U.S. but also abroad. Dr. Wittkowsky is highly respected by her peers and often consulted for guidance on patient care issues. She has been instrumental in developing numerous practice guidelines and protocols for anticoagulation management which have been utilized by practitioners throughout the nation to guide implementation of their own clinical services. The practice website (http://uwmcacc.org/) that she established at University of Washington is referred to not only by practitioners but also by national regulatory and quality groups such as The Joint Commission and The National Quality Forum.
Dr. Henry Bussey, professor at the University of Texas and president and senior editor of ClotCare.org, wrote in his letter of support,
For over two-decades, Dr. Wittkowsky has been an exemplary clinician and a true ambassador for clinical pharmacy. She has combined her experience in developing a well-known and highly respected patient care service at the University of Washington with an excellent program in applied clinical research. Her outstanding ability to make complex issues easy to understand has allowed her to be an outstanding speaker at numerous medical and pharmacy meetings. Such presentations are always top notch and among the best presentations I’ve heard.
Dr. Wittkowsky serves as an editorial board member for Pharmacotherapy and the Journal of Thrombosis and Thrombolysis, a reviewer for several medical and scientific journals, and a member of the board of directors of The Anticoagulation Forum, a multidisciplinary organization of anticoagulation care providers. She has been director of the Northwest Anticoagulation Consortium and preceptor for the ASHP Research and Education Foundation’s Antithrombotic Pharmacotherapy Traineeship; she has served on the Board of Regents of the American College of Clinical Pharmacy, the Board of Directors of Pharmacotherapy, and the National Certification Board of Anticoagulation Providers. Dr. Wittkowsky was a member of the American College of Chest Physician’s 8th Conference on Antithrombotic and Thrombolytic Therapy and an author for the ninth edition of these guidelines.